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Abstract
Background: It has been demonstrated that cerebral ischemia induces astrocyte reactivity, and subsequent glial scar
formation inhibits axonal regeneration during the recovery phase. Investigating the mechanism of glial scar formation will
facilitate the development of strategies to improve axonal regeneration. However, an in vitro model of ischemia-induced
glial scar has not yet been systematically established.
Methodology and Principal Findings: In the present study, we at the first time found that oxygen-glucose deprivation
(OGD) in vitro can induce rat cortical astrocytes to present characteristics of glial scar. After OGD for 6 h, astrocytes showed a
remarkable proliferation following 24 h reperfusion, evaluated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide assay and BrdU immunocytochemistry. Meanwhile, the expression of glial fibrillary acidic protein significantly
increased, so did the expression of neurocan, which is a hallmark of the glial scar. In further experiments, neurons were co-
cultured with astrocytes, which had been exposed to OGD, and then the immunostaining of class III b-tubulin was carried
out to assess the neurite growth. When the co-culture was performed at 48 h reperfusion of astrocytes, the neurite growth
was obviously inhibited, and this inhibition could be reversed by chondroitinase ABC, which digests glycosaminoglycan
chains on CSPGs, including neurocan. However, the processes of neurons were elongated, when the co-culture was
performed immediately after OGD.
Conclusions and Significance: Our results indicated that after conditioned OGD the astrocytes presented the characteristics
of the glial scar, which are also comparable to the astrocytes in acute and chronic phases after cerebral ischemia in vivo.
Therefore, the present system may be used as an in vitro model to explore the mechanisms underlying glial scar formation
and the treatments to improve axonal regeneration after cerebral ischemia.
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Introduction
Cerebral ischemia can lead to astrocyte activation and glial scar
formation [1,2,3]. Recent studies suggest that glial scar has a dual
role in central nervous system (CNS) repair after stroke [4,5,6]. In
the acute phase following ischemic injury, glial scar formation is
crucial for sealing the site of injury and remodeling the tissue, and
temporally and spatially controlling the local immune response
[6]. On the other hand, the glial scar, a barrier against neurite
growth, prevents the recovery of CNS function in the chronic
phase [7,8]. Thus, a detailed understanding of the glial scar,
including its formation and changes over time, is crucial to develop
effective therapeutic strategies for stroke patients.
Reactive astrocytes are the main cells consisting the glial scar,
although microglia are also included [6,9]. The processes of
astrocyte activation in response to CNS injuries have specific
structural and functional characteristics. Reactive astrocytes
upregulate expression of glial fibrillary acidic protein (GFAP)
and various extracellular matrix molecules, and begin proliferating
rapidly [5,10]. The extracellular matrix molecules present the
main barrier against axonal growth, which predominantly contain
chondroitin sulfate proteoglycans (CSPGs), such as neurocan and
phosphacan [8].
So far, little is known about the mechanisms underlying glial
scar formation, and few models of the glial scar in vitro have been
established. It has been reported that cultures stretched by abrupt
deformation of the silastic culture plates produce scar-like reactive
astrocytes [7]. In another model [11], reactive astrogliosis
gradually forms when injured by either a mechanical scrape or
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steel microwire). Some factors such as ATP, EGF, and TGF, play
an important role in the astrogliosis in vitro and in vivo, however,
whether the glial scar induced by such factors in vitro closely mimics
that after ischemia remains doubt, since there may exist complex
system to induce the glial scar after ischemia [12–14]. So, there is
no ideal in vitro model to mimic the glial scar induced by cerebral
ischemia, and to describe the acute and chronic phase changes of
astrocyte after cerebral ischemia.
In the present study, we found that oxygen-glucose deprivation
(OGD) in vitro can induce astrocytes to present characteristics of
glial scar, which play a dual role in neurite growth of neurons.
Results
Effect of OGD and Reperfusion Time on Reactive Gliosis
of Astrocytes
The effects of different OGD durations on 1-(4,5-dimethylthia-
zol-2-yl)-3,5-diphenylformazan (MTT) reduction were assessed
after different reperfusion times. We found that the MTT
reduction of astrocytes returned to control level when exposed to
2 h OGD followed by 24 h reperfusion. When exposed to OGD
for 12 h followed by 24 h reperfusion, the MTT reduction was
only 20% of controls, which indicated such exposure was too
severe (data not shown). Further, we tested three intermediate
durations of OGD, which were 4, 6 and 8 h, respectively. At
acute phase (0 h reperfusion), OGD for 4, 6 or 8 h caused a
significant decline of MTT reduction (Fig. 1A), indicating an
obvious decrease of viability at these conditions. However, after
24 h reperfusion, only 6 h of OGD caused a significant increase
of MTT reduction, which was possibly due to the proliferation.
After 48 h reperfusion, the MTT reductions of all the three
OGD-treatment groups were not significantly different from their
corresponding controls. We further investigated whether the
changes of MTT reduction were contributed by the proliferation
or death. Astrocytes only showed obvious increase of prolifera-
tion, by BrdU
+-labeling, at 24 h reperfusion after OGD (Fig. 2).
When reperfused for 24 h after 4 h OGD, the number of
proliferating cells in OGD group was 123% of that in control
group (Fig. 2A). While reperfused for 24 h after 6 h OGD, the
number of proliferating cells notably increased to nearly double
of the amount of controls (Fig. 2B, D). Thus, the duration of 6 h
for OGD was used in the following experiments, as it induced
the most obvious astrogliosis. Then cell apoptosis and necrosis
condition was analyzed by Hoechst 33342 and propidium iodide
double staining after 6 h OGD (Fig. 1B, C). At acute phase (0 h
reperfusion) and 48 h reperfusion after 6 h OGD, the percentage
of apoptosis significantly increased compared with controls, but
not at 24 h reperfusion after OGD. No signs of obvious necrosis
were detected at any of the time points after OGD, although it
(only about 0.14%) showed a significant increase at acute phase.
To ensure that OGD caused reactive astrocytes, we did the
GFAP immunocytochemistry staining at different durations of
reperfusion after OGD. The astrocytes became stellate and
clustered, and had extended processes in the acute phase (0 h
reperfusion) in response to OGD (Fig. 3A (d, g)), while the
astrocytes in controls showed a flat and polygonal morphology
(Fig. 3A (a)). The GFAP fluorescence intensity also increased
remarkably by 24% (control: 100.064.8%, OGD: 123.867.4%),
especially in stretched processes (Fig. 3A (g), B). At 24 h after
OGD, the astrocytes became hypertrophic (Fig. 3A (e, h)), and had
high GFAP fluorescence intensity in their cell body and processes.
Quantitative analysis showed that the mean fluorescence intensity
of GFAP in the OGD groups was 52% higher than that in the
control groups (control: 100.064.5%, OGD: 152.469.1%) after
reperfusion for 24 h (Fig. 3B). After reperfusion for 48 h, some
astrocytes still had high GFAP fluorescence intensity in their cell
Figure 1. The effects of different OGD durations on MTT
reduction and apoptosis and necrosis in astrocytes. Cells were
exposed to OGD for 4, 6 or 8 h, followed by reperfusion for 0, 24 or
48 h. The percentage of MTT reduction, apoptosis and necrosis was
assayed after various durations of reperfusion. Values are expressed as
percentage of control values and are from 3 to 6 independent
experiments. * P,0.05; ** P,0.01; *** P,0.001, compared with control
group.
doi:10.1371/journal.pone.0037574.g001
Ischemia Induced Glial Scar Formation In Vitro
PLoS ONE | www.plosone.org 2 May 2012 | Volume 7 | Issue 5 | e37574body or processes (Fig. 3A (f, i)), and by quantitative analysis the
immunoreactivity of GFAP in OGD groups remained 24% higher
than control groups (Fig. 3B). The Western blot analysis was also
performed to confirm the high expression of GFAP after OGD
(Fig. 3C). We found that the expression of GFAP was upregulated
after OGD similar as the immunocytochemistry results, but only
with significance at 0 h and 24 h after OGD.
OGD Upregulated Neurocan but Not Phosphacan
To further determine if OGD caused glial scar formation, we
evaluated the expression of the main scar-associated proteins,
neurocan and phosphacan, at different time points after OGD.
The expression of neurocan by immuocytochemistry assay showed
no differences between OGD and control groups in the acute
phase after OGD (Fig. 4A). However, the mean fluorescence
intensity of neurocan was notably upregulated by 53% in OGD
groups compared to control groups at reperfusion for 24 h
(Fig. 4B). Meanwhile, the expression of actin still remained the
same as controls (control: 10066.1%; OGD: 95.6612.4%; n=5,
P.0.05), suggesting the upregulation of neurocan was not the
result of false-positives but because of OGD (Fig. 4A). Secreted
neurocan levels from the conditioned medium were also increased
at 24 h after OGD (control: 1.0060.05, OGD: 1.4260.13) by
Western blot analysis (Fig. 4C). After 48 h reperfusion, the
expression of neurocan in the OGD groups returned to the control
values by immunocytochemistry analysis and Western blot analysis
(Fig. 4B, 4C). To confirm the change of neurocan in vitro was
similar as that in vivo after ischemia, the expression of neurocan in
the penumbra region was analyzed by immunostaining and
Western blot in rats. Seven days after ischemia induced by
tMCAO, the expression of neurocan showed obvious elevation
with the activation of astrocytes indicated by GFAP staining, but
its expression decreased to the level of control at 14 d after
ischemia (Fig. 5). The double positive yellow areas were present on
astrocytic cell bodies or processes at 7 d after tMCAO, which
suggested that astrocytes expressed neurocan after cerebral
ischemia (Fig. 5B).
The expression of phosphacan in astrocytes showed no
significant changes between OGD-treated and control astrocytes
after OGD by immunocytochemistry assay (Fig. 6A, B). Phospha-
can secretion was also assessed in conditioned medium from
controls and OGD treated astrocytes. To our surprise, phospha-
can secretion was dramatically decreased at 24 h after OGD to
only 61% of controls (Fig. 6C). After 48 h reperfusion, it was
reduced to 78% of controls, and then gradually recovered to
control levels at 72 h reperfusion (Fig. 6C).
Neurite Growth were Promoted in Acute Phase but
Inhibited after 48 h Reperfusion by Reactive Astrocytes
To study the effect of reactive astrocytes on neurite growth,
cultured neurons were seeded on astrocytes at three different
times after OGD. When neurons were co-cultured with
Figure 2. Proliferation of astrocytes were analyzed at various reperfusion times after OGD. Numbers of BrdU positive cells after BrdU
immunostaining (red) were qualified after 4 h (A), 6 h (B) or 8 h (C) OGD followed by indicated durations of reperfusion. The BrdU positive cells after
6 h OGD were shown in (D). Scale bars=200 mm. Values are from 3 to 6 independent experiments.
doi:10.1371/journal.pone.0037574.g002
Ischemia Induced Glial Scar Formation In Vitro
PLoS ONE | www.plosone.org 3 May 2012 | Volume 7 | Issue 5 | e37574Figure 3. GFAP expression and proliferation of astrocytes were analyzed at various reperfusion times after 6 h OGD. (A) GFAP
immunostaining(green)afterOGD.Controlastrocytesculturedfor0(a),24(b)and48 h(c)wereflatandpolygonal.AstrocytestreatedwithOGDbecame
stellateandclustered,extendedprocesses,andhadhighGFAPfluorescenceintensityinstretchedprocessesafter0 hreperfusion(d,boxindisenlargedin
g).After24 hreperfusion,astrocyteswerehypertrophic,andGFAPstainingintensitywasupregulatedincellbodyandprocesses(e,boxineisenlargedinh).
Andafter48 hreperfusion,someastrocytesstillhadhighGFAPfluorescenceintensityintheircellbodyorprocesses(f,boxinfisenlargedini).Figuresg,h
andiwereamplificationofboxesinfiguresd,eandf,respectively.Scalebars=100 mmfora-f;andscalebars=50 mmforg-i.(B)QuantificationofmeanGFAP
fluorescenceintensity.(C)WesternblotanalysisofGFAPexpression.Valuesarefrom3to 6independentexperiments.
doi:10.1371/journal.pone.0037574.g003
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than controls, in both the physically separated N model (OGD:
151.466.1%, control: 100.063.2%, Fig. 7A-C) and the directly
contacted A+N model (OGD: 119.763.7%, control:
100.063.4%, Fig. 8A-C), whereas there were no remarkable
changes in the number of neurites between controls and co-
cultured groups (data not shown). When co-culture was
performed at 24 h after OGD, the promoting effect on neurite
growth disappeared. The mean lengths of neurites showed no
notable difference between control and OGD groups (Fig. 7A,
B; 8A, B). Interestingly, when the co-culture was delayed to
48 h after OGD, reactive astrocytes inhibited neurite growth in
both models. Neurons grew many long processes and most of
them extended in the control groups (Fig. 7D, 8D), while many
neurite processes were stunted, and some had abrupt turns or
swollen endings in the OGD groups (Fig. 7D, 8D). Further-
more, control neurons had more connection and overlapping
processes with surrounding neurons, but neurons in the OGD
groups mostly appeared singly and lacked overlapping processes
(Fig. 7A, 8A). The mean length of neurites in the OGD groups
was reduced to 68.562.2% in the N model (Fig. 7B) and to
82.062.5% in the A+N model compared to control groups
Figure 4. Immunocytochemistry staining and Western blot analysis of neurocan at various reperfusion times after 6 h OGD. (A)
Neurocan (green) and actin (red) staining after OGD followed by indicated durations of reperfusion. Scale bars=100 mm. (B) Quantification of mean
neurocan fluorescence intensity. (C) Western blot analysis of neurocan secretion in conditioned medium from astrocytes (major core bands are about
130, 150, 190, and 270 kD). Values are expressed as percentage or fold change of control values and are from 3 to 6 independent experiments.
doi:10.1371/journal.pone.0037574.g004
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related to the expression of neurocan in astrocytes after OGD,
chondroitinase ABC (chABC) was added into the co-culture
system in N model, which digests glycosaminoglycan chains on
CSPGs and can thereby overcome CSPGs, including neurocan,
mediated inhibition. The neurite growth inhibition was signif-
icantly recovered by chABC, when the co-culture was
performed at 48 h after OGD (Fig. 9B, D). Moreover, chABC
even increased the neurite growth of neurons co-cultured at
24 h after OGD (Fig. 9A, C). However, chABC did not affect
the neurite growth in both control groups (data not shown).
Discussion
In the present study, we found that conditioned OGD (6 h) can
induce astrocytes to present characteristics of glia scar after
reperfusion, since astrocyte proliferation was increased and the
expression of GFAP and neurocan were significantly upregulated
following 24 h reperfusion. And these astrocytes play a dual role in
neurite growth of neurons, as the neurons grew longer processes
when the co-culture was performed immediately after OGD, but
neurite growth was notably inhibited in two co-culture models
when the co-culture was performed at 48 h of reperfusion after
OGD. These phenomena mimic the effects of reactive astrocytes
on nerve growth in vivo. Therefore, we considered that an in vitro
model of glial scar induced by OGD was established for the first
time, which is much useful for exploring the mechanisms
underlying glial scar formation after stroke.
Cerebral ischemia leads to widespread progressive alterations in
astrocytes, including cell hypertrophy, upregulation of intermedi-
ate filaments and increase in cell proliferation, which is commonly
referred to as reactive astrogliosis [1–3,15]. Here, we found that
after 6 h OGD and an additional 24 h reperfusion, the expression
of GFAP in astrocytes was significantly upregulated, and the
number of BrdU immunopositive cells also notably increased in
the OGD groups compared with controls. These results indicate
that the astrocytes exhibit reactive astrogliosis in response to OGD
during reperfusion. However, in our experiment, 6 h, but not 2 h,
4 h, 8 h or 12 h OGD caused mostly obvious proliferation of
astrocytes, which suggests that the moderate injury is the necessary
condition to induce glial scar-like changes of astrocytes. Such
phenomenon is reasonable, because the reactive astrocytes and the
glial scar formation exist in the penumbra, but not the core of the
ischemia, where the blood flow is far lower than normal level [16].
In addition, following 24 h reperfusion after OGD, the expression
of neurocan, a representative scar-associated hallmark [17–19],
Figure 5. Effect of cerebral ischemia on neurocan expression in the penumbra region in rats. Fluorescent double immunostaining of
neurocan and GFAP at 7 d after tMCAO in rats were performed (GFAP: red; neurocan: green; B (d-f) was the enlarged image from the penumbra
region indicated by arrow in A; B (a-c) showed the image of the same region in sham group). The negative control by doing the same
immunohistochemistry procedure without incubating with anti-neurocan was shown in g-i. DAB histochemistry staining of neurocan at different
reperfusion duration after tMCAO were performed and the image from the penumbra region or contralateral (contra) region are shown in C. (D)
Western blot analysis of neurocan expression (major core bands are about 150, 190, and 270 kD), which was normalized by GAPDH (,37 kD). A: scale
bars=1 mm; B, C: scale bars=25 mm. Values are expressed as percentage or fold change of control values and are from 3 to 6 rats.
doi:10.1371/journal.pone.0037574.g005
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that the expression of neuroncan showed an elevation at 7 d after
cerebral ischemia, and the high expression spots of neurocan were
well co-localized with astrocytes. Similar to our observations, other
groups found that neurocan accumulates and upregulates around
injuries responding to ischemia [19–22]. For example, Inatani et
al. reported that neurocan transiently appears in the peri-ischemic
region with a peak level at 4 days after tMCAO in rats [21]. Days
to one week or even longer after ischemia is often considered as
the subacute phase of the pathologic process after ischemia, during
which the astrocytes are activated, proliferate and secrete many
kinds of mediators including the neurocan [1]. Therefore, the 24 h
reperfusion after OGD in vitro is possibly comparable to the
subacute phase after ischemia in vivo, and study of the mechanism
of astrocyte changes during this phase could also be carried out in
vitro.
In addition, after stroke, the growth of neuronal axon is often
arrested and the endings of axon are swollen [23]. Such bulbous
axon terminals are considered signs of abortive regeneration, and
have been labeled ‘‘dystrophic endings’’ [7]. In the present study,
at 48 h reperfusion after OGD, the neurons exposed to OGD
treated astrocytes showed abortive regeneration, as they often
appeared singly with less overlapping, and had swollen terminals
or abrupt turns in neurite processes, the growth of which was also
inhibited. These morphologies are also consistent with neurons
responding to an inhibitory environment induced by other injuries
[7,9,11,24]. Moreover, we found that the neurite growth inhibition
was significantly reversed by chABC, which overcome the effect of
Figure 6. Immunocytochemistry staining and Western blot analysis of phosphacan at various reperfusion times after 6 h OGD. (A)
Phosphacan staining after OGD followed by indicated durations of reperfusion. Scale bars=100 mm. (B) Quantification of mean phosphacan
fluorescence intensity. (C) Western blot analysis of phosphacan secretion in conditioned medium from astrocytes. Values are expressed as percentage
or fold change of control values and are from 3 to 6 independent experiments.
doi:10.1371/journal.pone.0037574.g006
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that astrocytes at 48 h reperfusion after OGD in our experiment
present a glial scar-like action to inhibit neuron growth. The
astrocytes in other scar models induced by stretch [7] or
mechanical scraping [11], also show scar-associated changes and
present inhibitory effect on neuron growth, however which only
occurs adjacently to the lesion border but not far away from the
injuried tissues. Our present condition caused a more widespread
area with scar-like patterns. Moreover, ischemia and traumatic
insults arise from very different initial insults and lead to very
different pathophysiology, which means mechanical injury models
are not very suitable to study the pathologic mechanisms of
ischemic insults. Thus, our ischemia-induced model in vitro will be
helpful in exploring the mechanisms underlying glial scar
formation caused by ischemia.
Interestingly, we found different results when the co-culture was
performed at 0 h or 48 h of reperfusion. This indicated that
reactive astrocytes play different roles in the acute phase and the
later phase after OGD, which is similar to its functional roles in vivo
[1,15]. When the co-culture was made at the acute phase after
OGD, the neurons on treated astrocytes had elongated neurites,
which means OGD treated astrocyte improved neurite outgrowth.
Growing evidences show that astrocytes exert a neuroprotective
effect in the acute phase after stroke by shielding neurons from
oxidative stress [5], providing trophic and metabolic supports to
promote neuronal repair [25–27], or regulating excessive levels of
glutamate, K
+ and other ions [6]. These findings may help to
explain how reactive astrocytes promote neuronal repair and
survival in various ways during the acute phase after OGD, and
also support that the changes of astrocytes in our system mimic
those in vivo. On the other hand, when the co-culture was
performed at 48 h of reperfusion, neurite growth inhibition
occurred. But previous indexes to confirm the scar-like changes
all were made at 24 h of reperfusion. This seems paradoxical, but
is also interesting and complex. It may be attributed to the
following two reasons. (i) Reactive astrogliosis is a finely graded
continuum of progressive changes in gene expression and cellular
changes [28]. It takes a time from synthesis to release of inhibitory
proteins or cytokines by reactive astrocytes and from release to
exerting an influence on neurons. And a delay of 24 h or more
may be needed in our experiment. (ii) During the cerebral
ischemia and reperfusion, astrocytes might either reduce or
exacerbate the damage to neurons depending on the time point
or post-ischemic stage [10,29]. So, here may be due to the
simultaneous presence of neurite growth-promoting and growth-
inhibiting factors during 24 h reperfusion, which ultimately leads
to the positive and negative effects balancing out. We also found
that after treated with chABC, the neurite growth of neurons co-
Figure 7. Effect of co-culture with astrocytes on neurite growth in physically separated model (N model). (A) class III b-tubulin
immunostaining of embryonic cortical neurons after co-culture with astrocytes for 24 h. Before co-culture, astrocytes were subjected to 6 h OGD or
not followed by indicated durations of reperfusion. Scale bar=200 mm. (B) Quantification of mean neurite length per neuron. (C) Representative
figures of class III b-tubulin immunostaining of embryonic cortical neurons co-cultured with astrocytes for 24 h from 0 h reperfusion. Scale
bar=50 mm. (D) Representative figures of class III b-tubulin immunostaining of embryonic cortical neurons co-cultured with astrocytes for 24 h from
48 h reperfusion. Scale bar=50 mm. Values are from 3 to 6 independent experiments.
doi:10.1371/journal.pone.0037574.g007
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exist grow-inhibiting factors, like CSPGs, in the co-culture system
at 24 h after OGD.
The neurons in the in separated co-culture system showed more
obvious change in neurite outgrowth than that in co-culture
system with direct contact, as shown in Figs 7 and 8. In the acute
phase after OGD, the mean length of neurites in the A+N model
increased by 20% but more than 51% in the N model. During the
recovery phase, the mean length of neurites in the N model was
reduced to nearly 69% of controls, while it was reduced to 82% of
controls in the A+N model. It is likely that the direct contact
system is more stable and complex than the physically separated
system and less vulnerable to many kinds of stimulation [30–31].
We suppose that the difference may be related to the existence of
some factors, which are released or buffered by astrocytes only in
contact co-culture system, playing different roles in acute and
recovery phase after OGD, and further study is needed to
elucidate the detailed mechanism.
Phosphacan, another major component of the CSPG family
[15,32,33], is strongly up-regulated following various kinds of CNS
injury in vivo, such as spinal cord injury [9], trauma [8] and
ischemia [34,35]. It also inhibits neurite outgrowth from different
populations of neurons [36–39]. So, many studies regard
phosphacan as a hallmark of glial scar [7,32]. However, to our
surprise, we found that phosphacan was reduced at 24 h after
OGD and recovered to the control level at 72 h. Similar to our
results, after hypoxia-ischemia, the protein level of phosphacan is
reduced [19,40]. Jones et al. also reported that it decreases
immediately but later recovers and then peaks after 2 months
following spinal cord injury [33]. Considering the varying
expression according to different intensities of cellular response
and various kinds of CNS injury, it seems that phosphacan is not
an appropriate marker of glial scar.
In conclusion, we found that after conditioned OGD, the
astrocytes presented the characteristics of the glial scar, which are
also comparable to the astrocytes in acute and chronic phases after
cerebral ischemia in vivo. Therefore, the present system may be
used as an in vitro model to explore the mechanisms underlying
glial scar formation and the treatments to improve axonal
regeneration after cerebral ischemia, but direct evaluation for
drugs has not been performed. Moreover, the glial scar-like
change of astrocytes may not be persistent as that in vivo, and the
time window to induce glial scar-like change seems narrow, so
strictly controlling the experimental condition and examining the
glial scar formation index at the same time are necessary during
each test.
Methods
Ethics and Statement
All procedures were approved by the Zhejiang University
Animal Experimentation Committee (Zju2009-1-02-004) and
conformed to the National Institutes of Health Guide for the
Care and Use of Laboratory Animals. All efforts were made to
minimize the number of animals used, and their suffering.
Figure 8. Effect of co-culture with astrocytes on neurite growth in directly contacted model (A+N model). (A) Class III b-tubulin
immunostaining in embryonic cortical neurons after co-culture with astrocytes subjected to 6 h OGD or not followed by indicated durations of
reperfusion. Scale bar=200 mm. (B) Quantification of mean neurite length per neuron. (C) Representative figures of class III b-tubulin immunostaining
of embryonic cortical neurons co-cultured with astrocytes for 24 h from 0 h reperfusion. Scale bar=50 mm. (D) Representative figures of class III b-
tubulin immunostaining of embryonic cortical neurons co-cultured with astrocytes for 24 h from 48 h reperfusion. Scale bar=50 mm. Values are from
3 to 6 independent experiments.
doi:10.1371/journal.pone.0037574.g008
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Primary cortical astrocyte cultures were prepared from 24 h
postnatal Sprague-Dawley rats as described previously [41].
Briefly, the cerebral cortices were digested with 0.25% trypsin
for 15 min at 37uC, and then the dissociated cells were seeded
onto poly-D-lysine-coated 25 cm
2 flasks. Cells were cultured in
Dulbecco’s Modified Eagle Medium (DMEM, Invitrogen, USA)
supplemented with 10% fetal bovine serum, 2 mM L-glutamine,
100 units/ml penicillin and 100 mg/ml streptomycin. The cultures
were maintained at 37uC under .90% humidity and 5% CO2.
The medium was changed every 2–3 days until cells reached
confluence. After 12–14 days, the confluent cultures were shaken
Figure 9. Effect of co-culture with astrocytes on neurite growth after treated with chABC in physically separated model (N model).
Representative figures of class III b-tubulin immunostaining of embryonic cortical neurons after co-culture with astrocytes for 24 h from 24 h (A) or
48 h (B) reperfusion. chABC at 0.2 U/ml was added into the astrocytes at 2 h before co-culture. Quantification of mean neurite length for neurons
after co-culture with astrocytes for 24 h from 24 h (C) or 48 h (D) reperfusion. Scale bar=50 mm. Values are from 3 to 4 independent experiments.
doi:10.1371/journal.pone.0037574.g009
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astrocyte monolayers were trypsinized and replated at a density of
2.5610
4 cells/cm
2. More than 95% of the cultured cells were
astrocytes as identified by immunofluorescent staining for GFAP.
Oxygen-glucose Deprivation
Oxygen-glucose deprivation was performed as previously
described [19]. Briefly, astrocytes were incubated in DMEM
containing 2 mM L-glutamine, 100 units/ml penicillin, 100 mg/
ml streptomycin and 1% fetal bovine serum for 16 h, and then
washed twice and incubated in glucose-free DMEM (Invitrogen,
USA). Then the cultures were transferred into an anaerobic
chamber filled with a gas mixture of 95% N2/5% CO2 at 37uC. At
the end of the OGD, astrocytes were incubated in DMEM
containing 2 mM L-glutamine, 100 units/ml penicillin, 100 mg/
ml streptomycin and 1% fetal bovine serum, and reintroduced to
the regular atmospheric oxygen level for an additional 24, 48 or
72 h. In each experiment, cultures exposed to OGD were
compared with normoxic controls supplied with DMEM contain-
ing glucose and maintained in standard incubation conditions.
Primary Cortical Neuron Cultures
Primary cortical neurons were prepared from embryonic day
18 Sprague-Dawley rats as described previously [42] with the
following modifications. In brief, cortices were dissected from
the brains under sterile conditions, digested in 0.25% trypsin in
Hank’s balanced salt solution for 15 min at 37uC and then
mechanically dissociated. The cells were spun down for 5 min
at 1000 g and resuspended in Neurobasal medium (Invitrogen,
USA). Cells were seeded at a density of 1.5610
5 cells/cm
2 to
glass coverslips coated with poly-D-lysine (0.1 mg/ml, Sigma,
USA). Neurobasal medium was supplemented with 100 units/
ml penicillin, 100 mg/ml streptomycin, 0.5 mM L-glutamine
and 2% B-27. The cultures were maintained in a humidified
CO2 incubator (5% CO2, 95% air, 37uC). Neurons were used
for immunocytochemistry after co-culture with astrocytes for
24 h.
Astrocyte and Neuron Co-culture
Two co-culture methods were used in this system. In method A
(termed N), astrocytes were subcultured on Petri dishes and
subjected to OGD for 6 h. After different reperfusion times (0 h,
24 h, 48 h), four glass coverslips were placed on the bottom of the
dish. Then neurons were seeded on the coverslips, and cultured for
additional 24 h. To study the role of neurocan in the inhibition of
neurite growth, chABC at 0.2 U/ml was added at 2 h before the
seeding of neurons. In this method, neurons and astrocytes are
physically separated, but the medium was intermixed. In method
B (termed A+N), at first, glass coverslips were placed on the
bottom of a Petri dish. Astrocytes were subcultured on coverslips
and subjected to OGD for 6 h. After different reperfusion times
(0 h, 24 h, 48 h), neurons were seeded on the coverslips, and
cultured for additional 24 h. In this method, neurons and
astrocytes have direct contact. All the Petri dishes and glass
coverslips were coated previously with poly-D-lysine (0.1 mg/ml).
The controls were co-cultured with astrocytes, which had not been
exposed to OGD.
MTT Assay and Cell Apoptosis and Necrosis Study
For MTT assay, astrocytes were subcultured on 96-well plates.
The cells were incubated with MTT (Sangon, China) 0.5 mg/ml
as final concentration for 2 h at 37uC. Then, the supernatant layer
was removed, and 100 ml of dimethyl sulfoxide was added to each
well. MTT metabolism was quantified spectrophotometrically at
570 nm in a Biorad microplate reader. Results were expressed as
the percentage of MTT reduction, assuming the absorbance of
control cells was 100%. Moreover, Hoechst 33342 and propidium
iodide double staining was performed to evaluate the cell apoptosis
and necrosis after OGD [43]. A cell that shows nuclear
condensation and DNA fragmentation detected by Hoechst
33342 is undergoing apoptosis, while a cell that is permeable to
propidium iodide is undergoing necrosis.
Immunocytochemistry
Immunostaining was also performed in cultured astrocytes and
neurons as previously described [44]. Cells seeded on coverslips
were fixed with 4% paraformaldehyde for 15 min and incubated
in 3% bovine serum albumin (BSA) containing 0.1% Triton X-100
at 37uC for 1 h. Then primary antibodies in 3% BSA were applied
for 0.5 h at 37uC. For astrocytes, rabbit anti-GFAP (1:100,
Zhongshan, China), rabbit anti-neurocan (1:200, Boster, China)
and mouse anti-phosphacan (1:100, DSHB, USA) were used. For
neurons, mouse anti-class III b-tubulin (1:2000, Sigma, USA) was
used. After repeated washes in phosphate-buffered saline (PBS),
cells were incubated with secondary antibody in 3% BSA for 0.5 h
at 37uC. The secondary antibodies used in this experiments
included goat anti-rabbit IgG-Alexa 488 (1:300, Invitrogen, USA),
goat anti-mouse IgG-Alexa 488 (1:300, Invitrogen, USA) and goat
anti-mouse IgG-Alexa 594 (1:300, Invitrogen, USA). For actin
staining, cells were incubated in rhodamine-phalloidin (Molecular
Probes; 1:50, USA) at the same time. After further washing in
PBS, cultures were dried, coverslipped, and mounted onto glass
slides. Finally, the stained cells were observed under fluorescent
microscopy (Olympus BX51, Japan). The immunofluorescence
intensity of GFAP, neurocan and phosphacan for each field was
analyzed by NIH Image J software and then normalized by the cell
number. Five to eight random fields were analyzed for each
coverslip in every independent experiment, which was replicated
for 3–6 times.
Neurite Growth Quantification
The lengths of neurites in each neuron were traced manually
and quantified by NIH Image J software. Only cells with a valid
nucleus and cell body (class III b-tubulin-positive) were included in
the analysis. Mean neurite length for each neuron was determined
for 50–200 neurons per condition from three to six separate
experiments.
Proliferation Assay
To assess proliferation of glial cells in culture, cells were
incubated with 10 mM BrdU during OGD, for 24 h after OGD,
or for 24 h after 24 h reperfusion of OGD, after which the cells
were fixed with 100% ice-cold methanol for 10 min at 4uC.
And then the cells were washed in PBS for 3 min, and the
DNA was denatured by incubating in 2 M HCl at 37uC for
1 h. After washed twice in 0.1 M borate buffer (pH 8.5) and
three times in PBS, cells were blocked with 3% BSA at 37uC
for 1 h. After that, cells were incubated in mouse monoclonal
antibody against 5-bromodeoxyuridine (BrdU, 1:2000, Sigma,
USA) at 37uC for 0.5 h and then washed twice with PBS. Cells
were then incubated with goat anti-mouse IgG-Alexa 594
(1:300, Invitrogen, USA) at 37uC for 0.5 h. After further
washing in PBS, cells were mounted, and observed under
fluorescent microscopy (Olympus BX51, Japan). Cell number
was counted by NIH Image J software.
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Adult male Spraque Dawley rats (250–280 g) were anesthetized
with chloral hydrate (350 mg/kg), and subjected to transient
middle cerebral artery occlusion (tMCAO). In brief, a silicone-
coated suture with round tip was inserted into the right internal
carotid to enter the origin of the middle cerebral artery. After
occlusion for 90 min, the suture was withdrawn to induce
reperfusion. After different during of reperfusion, the penumbra
region of the rats were separated for Western blot analysis, or the
rats were transcardially perfused by 0.9% cold saline and 4%
paraformaldehyde. The brains were separated and stored in 4%
paraformaldehyde at 4uC for 24 h, and then in 30% sucrose for
3 d. The dissected brains were then cut into 10 mM coronal
cryosections by a cryostat (SM2000R, LEICA, Germany) and
immunostained for neurocan and GFAP. For fluorescent immu-
nostaining, the sections were first incubated with 3% BSA in PBS
for 30 min, and then with rabbit anti-neurocan (1:100, Boster,
China) and mouse anti-GFAP (1:300, Millipore, USA) in PBS
containing 0.3% Triton X-100 at 4uC overnight. After washing
three times for 10 min with PBS, sections were incubated
sequentially in goat anti-rabbit IgG-Alexa 488 (1:200) and goat
anti-mouse IgG-Alexa 594 (1:300, Invitrogen, USA) serum for 2 h
at room temperature. For diaminobenzidine (DAB) histochemistry
staining, endogenous peroxidases were quenched by treatment
with 3% H2O2 in methanol, and slides were blocked with 10%
normal goat serum. Slides were then stained with rabbit anti-
neurocan (1:200, Boster, China) and were processed by using
Histostain-Plus IHC Kit (MR Biotech, China) and hemotoxylin
counterstain (KeyCEN BioTECH). Then the sections were
mounted after washing three times for 10 min with PBS. Images
of penumbra region in the stratium were captured under
fluorescent microscopy (Olympus BX61, Japan).
Western Blot
For neurocan and phosphacan expression after OGD, identical
amounts (500 mL) of astrocyte supernatant, after various treat-
ments, were concentrated by Amicon Ultra-0.5 ml Centrifugal
Filters (100 kD, Millipore) and centrifugation at 10000 g, 4uC for
25 min. For the neurocan expression after tMCAO in rats, total
proteins in the penumbra were purified using cell and tissue
protein extraction reagents (Kangchen, Shanghai, China). Protein
concentration was determined with the bicinchoninic acid assay
(Pierce, USA). Then protein samples were digested with 0.5 U/ml
chondroitinase ABC (Chase ABC, Sigma, USA) in Tris buffer
(50 mM Tris, pH 8.0, 60 mM sodium acetate and 0.02% bovine
serum albumin) at 37uC for 1.5 h, and then denatured with
loading buffer for 5 min. Protein samples were separated on 7.5%
SDS-polyacrylamide gels and then electrotransferred onto a
nitrocellulose membrane. After blocking with 5% fat free milk,
the membranes were incubated with rabbit anti-neurocan (1:400,
Boster, China), mouse anti-phosphacan (1:1000, Sigma, USA),
rabbit anti-GFAP (1:300, Boster, China) or mouse anti-glyceral-
dehyde-3-phosphate dehydrogenase (anti-GAPDH, 1:5000, Kang-
chen, Shanghai, China) at 4uC overnight. After repeated washes,
the membranes were reacted with IRDye 800 anti-rabbit
Molecular Probe (1:8000, LI-COR Biosciences, USA) or IRDye
700 anti-mouse Molecular Probe (1:3000, LI-COR Biosciences,
USA) for 2 h. Images were acquired with the Odyssey infrared
imaging system (LI-COR Biosciences, USA) and analyzed by the
software as specified in the Odyssey software manual.
Statistical Analysis
All data represent three or more independent experiments. Data
are presented as mean 6 SEM. Two tailed-Student’s t-test was
applied for comparisons between control and OGD group. One-
way ANOVA followed by the LSD or Dunnett’s T3 post-hoc test
(where equal variances were not assumed) was applied for multiple
comparisons. P,0.05 was considered statistically significant.
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